InsidersTradesSigma
Prostatype Genomics AB Stock: price and insider trades · Finland · FIN-FSA
Track the Prostatype Genomics AB share price and the full management transaction log of the company, a listed equity based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Prostatype Genomics AB has recorded 1 reports. Market capitalisation: €41.3m. The latest transaction was disclosed on 11 June 2025 (Purchase). Among the most active insiders: Michael Häggman. The full history is openly available.
1
Insider Decl.
0
Thresholds
€20,827
1 ops.
Buy Volume
·
0 ops.
Sell Volume
21Σ signal
Fundamental score
Ranked 22,427 of 25,921 companies
25.3
score / 100
Value1
Quality50
FCF yld-134%
Earn yld-160%
EV/EBITDA·
ROE-148%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 June 2025
Declarations1 total
57,090 shares@ €0.36480.050% mcap100.0% of flowBTU (betald tecknad unit)FI:A003P638-1
Ideal exit: 2 Mar 2026 (T+270)
1 of 1 declaration